Hepatobiliary Cancers: Pathobiology and Translational Advances | EK29
Mar 21, 2021 ‐ Mar 23, 2021
Sessions
![[Joint Session] Welcoming Remarks and Keynote Session icon](https://opus-nc-public.digitellcdn.com/assets/img/ks/product_icons/1605937d431d3c.png){kind=icon}
[Joint Session] Welcoming Remarks and Keynote Session
Preview Available
[Joint Session] Welcoming Remarks and Keynote Session
Mar 22, 2021 9:00am ‐ Mar 22, 2021 10:10am
Co-Chair(s):- Jay D. Horton, MD, University of Texas Southwestern Medical Center
- Alphonse E. Sirica, PhD, Virginia Commonwealth University
Changing Epidemiological Trends in Non-Alcoholic Fatty Liver Disease versus Viral-Associated Hepatobiliary Cancers
Preview Available
Changing Epidemiological Trends in Non-Alcoholic Fatty Liver Disease versus Viral-Associated Hepatobiliary Cancers
Mar 22, 2021 9:35am ‐ Mar 22, 2021 10:10am
Speaker(s):- Hashem B. El-Serag, MD, Baylor College of Medicine
![[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers icon](https://opus-nc-public.digitellcdn.com/assets/img/ks/product_icons/16059d9c3d4f40.png){kind=icon}
[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers
Preview Available
[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers
Mar 22, 2021 10:10am ‐ Mar 22, 2021 12:00pm
Co-Chair(s):- Jay D. Horton, MD, University of Texas Southwestern Medical Center
- Alphonse E. Sirica, PhD, Virginia Commonwealth University
A TGF-ß-ALDH2 Axis in Obesity, Metabolic Syndrome, and HCC
Preview Available
A TGF-ß-ALDH2 Axis in Obesity, Metabolic Syndrome, and HCC
Mar 22, 2021 10:10am ‐ Mar 22, 2021 10:35am
Speaker(s):- Lopa Mishra, MD, George Washington University
The Gut-Liver Axis in Liver Cancer Risk Conditions
Preview Available
The Gut-Liver Axis in Liver Cancer Risk Conditions
Mar 22, 2021 10:55am ‐ Mar 22, 2021 11:20am
Speaker(s):- Maria Rescigno, PhD, Humanitas University
Lipid Dysregulation in Inflammation, NASH, and Cancer
Preview Available
Lipid Dysregulation in Inflammation, NASH, and Cancer
Mar 22, 2021 11:20am ‐ Mar 22, 2021 11:45am
Speaker(s):- Daniel A. Heller, PhD, Memorial Sloan Kettering Cancer Center
Short Talk: The α1-Na/K-ATPase/Src-p/PI3K Pathway Modulates the Survivin-SMAC Apoptotic “Switch” in NASH Related Hepatocellular Carcinoma: A Translational Study
Preview Available
Short Talk: The α1-Na/K-ATPase/Src-p/PI3K Pathway Modulates the Survivin-SMAC Apoptotic “Switch” in NASH Related Hepatocellular Carcinoma: A Translational Study
Mar 22, 2021 11:45am ‐ Mar 22, 2021 12:00pm
Speaker(s):- Juan R. Sanabria, MD, Marshall University/Case Western Reserve University
Tumor Microenvironment and Hepatobiliary Cancers
Preview Available
Tumor Microenvironment and Hepatobiliary Cancers
Mar 22, 2021 4:00pm ‐ Mar 22, 2021 7:10pm
Co-Chair(s):- Lopa Mishra, MD, George Washington University
- Gregory J. Gores, MD, Mayo Clinic
Role of Cancer Associated Fibroblasts in Cholangiocarcinoma
Preview Available
Role of Cancer Associated Fibroblasts in Cholangiocarcinoma
Mar 22, 2021 4:00pm ‐ Mar 22, 2021 4:30pm
Speaker(s):- Silvia Affo, PhD, Columbia University
Mechanisms of Immune Escape in Hepatocellular Carcinoma
Preview Available
Mechanisms of Immune Escape in Hepatocellular Carcinoma
Mar 22, 2021 4:30pm ‐ Mar 22, 2021 5:00pm
Speaker(s):- Amaia Lujambio, PhD, Icahn School of Medicine at Mount Sinai